hydrogen carbonate has been researched along with lansoprazole in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Inada, I; Satoh, H | 1 |
| Kato, S; Konaka, A; Nishijima, M; Takeuchi, K; Yasuhiro, T | 1 |
| Eiro, M; Katoh, T; Watanabe, T | 1 |
| Girish, RK; Mishra, PK; Nagappa, AN; Pandi, PV; Shanmukh, I | 1 |
| Liu, F; Shokrollahi, H | 1 |
| Cao, P; Deng, Y; Liu, Q; Wu, J; Wu, S; Yang, Q; Yu, L; Zhai, X; Zhang, Q; Zhang, Y | 1 |
1 trial(s) available for hydrogen carbonate and lansoprazole
| Article | Year |
|---|---|
Pharmacokinetics and Pharmacodynamics of Lansoprazole/Sodium Bicarbonate Immediate-release Capsules in Healthy Chinese Subjects: An Open, Randomized, Controlled, Crossover, Single-, and Multiple-dose Trial.
Topics: Bicarbonates; Capsules; Cross-Over Studies; Drug Combinations; East Asian People; Healthy Volunteers; Humans; Lansoprazole; Sodium Bicarbonate | 2023 |
5 other study(ies) available for hydrogen carbonate and lansoprazole
| Article | Year |
|---|---|
Capsaicin-sensitive sensory neurons are involved in bicarbonate secretion induced by lansoprazole, a proton pump inhibitor, in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Bicarbonates; Capsaicin; Duodenum; Famotidine; Histamine H2 Antagonists; Intestinal Mucosa; Lansoprazole; Male; Neurons, Afferent; Omeprazole; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley; Stimulation, Chemical; Vasoactive Intestinal Peptide | 1996 |
Effects of pantoprazole, a novel H+/K+-ATPase inhibitor, on duodenal ulcerogenic and healing responses in rats: a comparative study with omeprazole and lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetic Acid; Animals; Anti-Ulcer Agents; Benzimidazoles; Bicarbonates; Dose-Response Relationship, Drug; Duodenal Ulcer; Enzyme Inhibitors; Epirizole; Gastric Acid; Lansoprazole; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley; Sulfoxides; Wound Healing | 1999 |
Use of a proton-pump inhibitor for metabolic disturbances associated with anorexia nervosa.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Alkalosis; Anorexia Nervosa; Bicarbonates; Bulimia; Chlorides; Female; Humans; Hypokalemia; Lansoprazole; Omeprazole; Proton Pump Inhibitors | 2002 |
Transport through liquid membranes containing omeprazole and lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Bicarbonates; Biochemistry; Cations; Chemistry, Pharmaceutical; Chlorides; Cholesterol; Drug Design; Enzyme Inhibitors; Hydrogen-Ion Concentration; Ions; Lansoprazole; Lecithins; Membranes, Artificial; Models, Biological; Models, Chemical; Molecular Conformation; Omeprazole; Permeability | 2002 |
In vitro dissolution of proton-pump inhibitor products intended for paediatric and geriatric use in physiological bicarbonate buffer.
Topics: Age Factors; Bicarbonates; Buffers; Chemistry, Pharmaceutical; Esomeprazole; Geriatrics; Humans; Hydrogen-Ion Concentration; Kinetics; Lansoprazole; Omeprazole; Particle Size; Pediatrics; Phosphates; Proton Pump Inhibitors; Sodium Chloride; Solubility; Tablets, Enteric-Coated; Technology, Pharmaceutical | 2015 |